Clinical Trial Update: Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating short-course intermittent regimens for HIV-associated tuberculosis. The status of the trial is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Snippet

Sponsor: Tuberculosis Research Centre, India | Conditions: Tuberculosis, Human Immunodeficiency Virus Infections | Phase 3 | Status: UNKNOWN